![Zhi Yuan Chang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zhi Yuan Chang
Chief Executive Officer at Chongqing Genrix Biopharmaceutical Co., Ltd.
Net worth: 13 M $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Chun Sheng Li | M | - |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 years |
Ji Kuan Shan | M | 52 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 9 years |
Yun Tong Hu | M | 42 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 years |
Zhi Gang Liu | M | 51 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 4 years |
Li Wen Liu | M | 33 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 years |
Dong Zhi Wei | M | 61 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 years |
Li Chen | M | 47 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 years |
Ren Sheng Jiang | M | 71 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 years |
Jia Qian Yang | F | 42 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 years |
Min Kou | F | 39 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 7 years |
Hong Fan | F | 36 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 7 years |
Jun Hua Qian | M | 57 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
China | 12 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Zhi Yuan Chang
- Personal Network